Invention Grant
- Patent Title: Anticancer agent
-
Application No.: US16907463Application Date: 2020-06-22
-
Publication No.: US11267797B2Publication Date: 2022-03-08
- Inventor: Yoshinobu Yoshimura , Masayasu Kasai , Yoshimichi Shoji , Shigemitsu Takeda
- Applicant: Kyoto Pharmaceutical Industries, Ltd. , Sumitomo Dainippon Pharma Co., Ltd.
- Applicant Address: JP Kyoto; JP Osaka
- Assignee: Kyoto Pharmaceutical Industries, Ltd.,Sumitomo Dainippon Pharma Co., Ltd.
- Current Assignee: Kyoto Pharmaceutical Industries, Ltd.,Sumitomo Dainippon Pharma Co., Ltd.
- Current Assignee Address: JP Kyoto; JP Osaka
- Agency: Leydig, Voit & Mayer, Ltd.
- Priority: JPJP2014-119113 20140609,JPJP2015-021492 20150205
- Main IPC: C07D307/92
- IPC: C07D307/92 ; C07H15/26 ; A61P35/00 ; C07D405/12 ; C07D407/12 ; C07F9/655 ; C07H7/06
Abstract:
The problem of the present invention is to provide a useful prodrug compound of a naphthofuran compound. The present invention relates to a compound represented by the formula (IA): [wherein each symbol is as described in the DESCRIPTION] or a pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20200317630A1 ANTICANCER AGENT Public/Granted day:2020-10-08
Information query
